BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12200621)

  • 1. Methylation of the p73 gene in gliomas.
    Watanabe T; Huang H; Nakamura M; Wischhusen J; Weller M; Kleihues P; Ohgaki H
    Acta Neuropathol; 2002 Oct; 104(4):357-62. PubMed ID: 12200621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation.
    Corn PG; Kuerbitz SJ; van Noesel MM; Esteller M; Compitello N; Baylin SB; Herman JG
    Cancer Res; 1999 Jul; 59(14):3352-6. PubMed ID: 10416592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 promoter methylation in human gliomas.
    Amatya VJ; Naumann U; Weller M; Ohgaki H
    Acta Neuropathol; 2005 Aug; 110(2):178-84. PubMed ID: 16025287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of mutation of the p73 gene in astrocytic neoplasms.
    Alonso ME; Bello MJ; Lomas J; Gonzalez-Gomez P; Arjona D; De Campos JM; Gutierrez M; Isla A; Vaquero J; Rey JA
    Int J Oncol; 2001 Sep; 19(3):609-12. PubMed ID: 11494043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population.
    Palani M; Devan S; Arunkumar R; Vanisree AJ
    Med Oncol; 2011 Dec; 28 Suppl 1():S445-52. PubMed ID: 20844987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P73 gene expression in ovarian cancer tissues and cell lines.
    Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
    Clin Cancer Res; 2000 Oct; 6(10):3910-5. PubMed ID: 11051237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas.
    Martinez-Delgado B; Melendez B; Cuadros M; Jose Garcia M; Nomdedeu J; Rivas C; Fernandez-Piqueras J; Benítez J
    Int J Cancer; 2002 Nov; 102(1):15-9. PubMed ID: 12353228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of multiple genes in astrocytic gliomas.
    Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
    Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific patterns of gene methylation in natural killer cell lymphomas : p73 is consistently involved.
    Siu LL; Chan JK; Wong KF; Kwong YL
    Am J Pathol; 2002 Jan; 160(1):59-66. PubMed ID: 11786399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.
    Yu J; Zhang H; Gu J; Lin S; Li J; Lu W; Wang Y; Zhu J
    BMC Cancer; 2004 Sep; 4():65. PubMed ID: 15367334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent epigenetic inactivation of the SLIT2 gene in gliomas.
    Dallol A; Krex D; Hesson L; Eng C; Maher ER; Latif F
    Oncogene; 2003 Jul; 22(29):4611-6. PubMed ID: 12881718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of p73, p21 and MDM2 proteins in gliomas.
    Kamiya M; Nakazato Y
    J Neurooncol; 2002 Sep; 59(2):143-9. PubMed ID: 12241107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant promoter hypermethylation profile of cell cycle regulatory genes in malignant astrocytomas.
    Ohta T; Watanabe T; Katayama Y; Yoshino A; Yachi K; Ogino A; Komine C; Fukushima T
    Oncol Rep; 2006 Nov; 16(5):957-63. PubMed ID: 17016577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis of the p51 gene and correlation between p53, p73, and p51 expressions in prostatic carcinoma.
    Takahashi H; Fukutome K; Watanabe M; Furusato M; Shiraishi T; Ito H; Suzuki H; Ikawa S; Hano H
    Prostate; 2001 May; 47(2):85-90. PubMed ID: 11340630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant transformation-related genes in meningiomas: allelic loss on 1p36 and methylation status of p73 and RASSF1A.
    Nakane Y; Natsume A; Wakabayashi T; Oi S; Ito M; Inao S; Saito K; Yoshida J
    J Neurosurg; 2007 Aug; 107(2):398-404. PubMed ID: 17695396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of p73 expression in six non-small cell lung cancer cell lines is associated with 5'CpG island methylation.
    Liu K; Zhan M; Zheng P
    Exp Mol Pathol; 2008 Feb; 84(1):59-63. PubMed ID: 18022156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation-independent silencing of the p73 gene in neuroblastoma.
    Banelli B; Casciano I; Romani M
    Oncogene; 2000 Sep; 19(39):4553-6. PubMed ID: 11002429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p73 gene is not mutated in oligodendrogliomas which frequently have a deleted region at chromosome 1p36.3.
    Tsujimoto T; Mochizuchi S; Iwadate Y; Namba H; Nagai M; Kawamoto T; Sunahara M; Yamaura A; Nakagawara A; Sakiyama S; Tagawa M
    Anticancer Res; 2000; 20(4):2495-7. PubMed ID: 10953317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
    Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS
    Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.